4'-hydroxydiclofenac has been researched along with warfarin in 2 studies
| Studies (4'-hydroxydiclofenac) | Trials (4'-hydroxydiclofenac) | Recent Studies (post-2010) (4'-hydroxydiclofenac) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
|---|---|---|---|---|---|
| 43 | 0 | 25 | 36,573 | 2,143 | 14,728 |
| Protein | Taxonomy | 4'-hydroxydiclofenac (IC50) | warfarin (IC50) |
|---|---|---|---|
| Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bencsik, T; Boda, G; Kroon, PA; Lemli, B; Needs, PW; Poór, M | 1 |
| Bedwell, DW; Hall, SD; Mohutsky, MA; Rougée, LRA; Ruterbories, KJ | 1 |
2 other study(ies) available for 4'-hydroxydiclofenac and warfarin
| Article | Year |
|---|---|
Interaction of quercetin and its metabolites with warfarin: Displacement of warfarin from serum albumin and inhibition of CYP2C9 enzyme.
Topics: Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2C9 Inhibitors; Diclofenac; Drug Interactions; Flavonoids; Humans; Metabolome; Quercetin; Serum Albumin; Spectrometry, Fluorescence; Ultrafiltration; Warfarin | 2017 |
The Impact of the Hepatocyte-to-Plasma pH Gradient on the Prediction of Hepatic Clearance and Drug-Drug Interactions for CYP2C9 and CYP3A4 Substrates.
Topics: Computer Simulation; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dextromethorphan; Diclofenac; Drug Interactions; Female; Hepatocytes; Humans; Hydrogen-Ion Concentration; Kinetics; Male; Midazolam; Plasma; Testosterone; Warfarin | 2017 |